Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000165081 | SCV000215784 | likely benign | Hereditary cancer-predisposing syndrome | 2014-07-21 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV001704200 | SCV000516559 | likely benign | not provided | 2018-10-25 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001248472 | SCV001421960 | likely benign | Ataxia-telangiectasia syndrome | 2024-01-16 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000165081 | SCV002536012 | uncertain significance | Hereditary cancer-predisposing syndrome | 2022-02-22 | criteria provided, single submitter | curation | |
Myriad Genetics, |
RCV004589764 | SCV005083906 | benign | Familial cancer of breast | 2024-05-14 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |